FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology and cardiology, and deals with treatment or prevention of thrombosis. For this purpose dabigatran etexilate is introduced in a dose from 150 to 300 mg twice per day.
EFFECT: method provides prevention of thromboembolic complications and development of stroke in patients with atrial fibrillation, who have creatinine clearance less than 80 ml/min with an absence of additional factors of risk of massive bleeding.
7 cl, 7 tbl, 4 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PERORAL DABIGATRAN ETEXILATE PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2633482C2 |
| ANTICOAGULANT DRUG, WHICH IS A SYNTHETIC DIPEPTIDE Ac-Trp-Arg-Pip·HCl, A PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTICOAGULANT DRUG | 2019 |
|
RU2712194C1 |
| METHOD FOR ANTICOAGULANT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH SEVERE BRAIN DAMAGE IN A CHRONIC CRITICAL CONDITION | 2021 |
|
RU2762945C1 |
| TREATMENT OF HYPERTENSION AND/OR PREVENTION AND TREATMENT OF HEART FAILURE IN MAMMAL, RECEIVING ANTICOAGULANT THERAPY | 2011 |
|
RU2564941C2 |
| METHOD OF TREATING OR PREVENTING ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION IN PAST HISTORY | 2016 |
|
RU2707959C2 |
| METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM | 2011 |
|
RU2611662C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| METHOD FOR TREATMENT OF THROMBOTHIC DISTURBANCES USING QUERCETIN-CONTAINING COMPOSITIONS | 2012 |
|
RU2642983C2 |
| METHOD FOR ASSESSING RISK OF BLEEDING DURING AND AFTER DENTAL INTERVENTIONS IN PATIENTS TAKING ORAL ANTICOAGULANTS | 2023 |
|
RU2813439C1 |
| METHOD OF PREVENTIVE TREATMENT OF STROKE | 2006 |
|
RU2324481C1 |
